Platform that predicts disease and phenotype dir
Author: Michael
New Longitude Prize to award £7.
FastWave’s Sola IVL device completes first-in-
Company’s antibody profiling technology could
New review from global geroscience experts maps
Combining next generation sequencing with advanc
New review explores metformin’s expanding pote
Companies harness AI to identify drugs that targ
Small-scale study of once-daily oral drug demons
RenewalBio is targeting longevity with a unique